> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç
Á¦¸ñ | 2023³â 3¿ù 30ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª | ||
---|---|---|---|
ÀÛ¼ºÀÚ | °ü¸®ÀÚ | ÀÛ¼ºÀÏ | 2023-03-24 |
¼¿ï´ëÇб³ »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿°íÀÚ ÇÏ¿À´Ï ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù. ¼¼¹Ì³ª´Â ZoomÀ» ÅëÇÑ ¿Â¶óÀÎ °ÀÇ·Î ¿¹Á¤µÇ¾î ÀÖÀ¸¸ç °ÀÇ¿¡ Âü¿©ÇÏ°íÀÚ ÇϽô ºÐ²²¼´Â ¾Æ·¡ÀÇ ¸µÅ©·Î Âü¿© ºÎŹµå¸®°Ú½À´Ï´Ù. *ÁÜÀ¸·Î Âü¼®Çϱâ À§Çؼ´Â "Âü¼®ÀڷΠȸÀÇ Âü°¡" --> À̸§, ¼º, À̸ÞÀÏ ÁÖ¼Ò, À̸ÞÀÏ ÁÖ¼Ò È®ÀÎÀ» ÀÔ·ÂÇÏ½Ã°í µî·ÏÇϽøé ȸÀÇ Âü¼®ÀÌ °¡´ÉÇÕ´Ï´Ù. ÀϽÃ: 2023³â 3¿ù 30ÀÏ ¸ñ¿äÀÏ ¿ÀÀü 11½Ã ¿¬»ç: Á¶³²Çõ ±³¼ö´Ô (¼¿ï´ëÇб³) Zoom link: http://snu-ac-kr.zoom.us/s/94062169492 Title: Evolution and Pathogenesis of Human Coronaviruses Nam-Hyuk Cho Department of Microbiology and Immunology, Seoul National University College of Medicine Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and often results in fatal pneumonia. Despite the worldwide effect of the COVID-19 pandemic, the underlying mechanisms of the fatal viral pneumonia remain elusive. In order to characterize the inflammatory features associated with the viral pneumonia in COVID-19 patients, clinical specimens, including bronchoalveolar lavage fluids (BALFs), sputa, lung biopsies, and bloods collected from confirmed cases of COVID-19 patients with varying degrees of disease severity were extensively analysed. In addition, we also examined and compared the viral dynamics and systemic immune responses observed in patients with COVID-19 and Middle Ease Respiratory Syndrome (MERS). Kinetic profiling of multiple inflammatory mediators showed complex dysregulation of innate and adaptive immune responses, which also associated with differential pulmonary inflammation in COVID-19 and MERS. In this presentation, I will also present and discuss evolutionary pathways of the emerging coronavirus infections, COVID-19 and MERS, which often resulting in fatal pneumonia. |
|||